|
Originally published In Press as doi:10.1074/jbc.M708137200 on October 17, 2007
J. Biol. Chem., Vol. 282, Issue 51, 37244-37255, December 21, 2007
Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors*
Giorgio Lagna 1,
Manching M. Ku ,
Peter H. Nguyen ,
Nicole A. Neuman ,
Brandi N. Davis , and
Akiko Hata
From the
Molecular Cardiology Research Institute, Tufts-New England Medical Center and the Department of Biochemistry, Tufts University School of Medicine, Boston, Massachusetts 02111
Vascular smooth muscle cells (VSMCs), unlike other muscle cells, do not terminally differentiate. In response to injury, VSMCs change phenotype, proliferate, and migrate as part of the repair process. Dysregulation of this plasticity program contributes to the pathogenesis of several vascular disorders, such as atherosclerosis, restenosis, and hypertension. The discovery of mutations in the gene encoding BMPRII, the type II subunit of the receptor for bone morphogenetic proteins (BMPs), in patients with pulmonary arterial hypertension (PAH) provided an indication that BMP signaling may affect the homeostasis of VSMCs and their phenotype modulation. Here we report that BMP signaling potently induces SMC-specific genes in pluripotent cells and prevents dedifferentiation of arterial SMCs. The BMP-induced phenotype switch requires intact RhoA/ROCK signaling but is not blocked by inhibitors of the TGFβ and PI3K/Akt pathways. Furthermore, nuclear localization and recruitment of the myocardin-related transcription factors (MRTF-A and MRTF-B) to a smooth muscle -actin promoter is observed in response to BMP treatment. Thus, BMP signaling modulates VSMC phenotype via cross-talk with the RhoA/MRTFs pathway, and may contribute to the development of the pathological characteristics observed in patients with PAH and other obliterative vascular diseases.
Received for publication, October 1, 2007
, and in revised form, October 16, 2007.
* This work was supported by NHLBI (National Institutes of Health) (to A. H.) and the American Heart Association (to G. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1-S3.
1 To whom correspondence should be addressed: MCRI, Tufts-New England Medical Center, 750 Washington St., Box 8486, Boston, MA 02111. Tel.: 617-636-4994; Fax: 617-636-5649; E-mail: glagna{at}tufts-nemc.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. A. Neuman, S. Ma, G. R. Schnitzler, Y. Zhu, G. Lagna, and A. Hata
The Four-and-a-half LIM Domain Protein 2 Regulates Vascular Smooth Muscle Phenotype and Vascular Tone
J. Biol. Chem.,
May 8, 2009;
284(19):
13202 - 13212.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. N. Davis, A. C. Hilyard, P. H. Nguyen, G. Lagna, and A. Hata
Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype
J. Biol. Chem.,
February 6, 2009;
284(6):
3728 - 3738.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|